GrayMatters Health granted clearance from FDA to Market Prism for PTSD
Non-Invasive, Self-Neuromodulation, Adjunct to Standard of Care Therapy Using Amygd…
Author: Digital Health Global
Pear Therapeutics voluntarily files for Chapter 11
Pear Therapeutics, Inc. has announced that it and its subsidiary, Pear Therapeutics…
Insomnia: China’s Use of Digital Cognitive Behavioral Therapy
Sleep problems like insomnia affect people all over the world with about 15% of peo…
A roadmap by the FDA for incorporating digital health technologies in clinical trials
The FDA has announced several guidelines and plans to hold at least one public meet…
Check out the Future Health Report: Expert Opinion on “Digital Therapeutics to enhance the care pathways for depression across the national health service: expert proposals for Italy”
The document describes five expert proposals and a possible clinical-organizational…
Labviva Secures $20M in Series A Financing to Transform the Life Sciences Procurement Industry Using AI
- Funding led by Biospring Partners with participation from existing investors. …
ReCode Therapeutics to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a genetic medicines compa…
Mental Health Leader SonderMind to Provide More Personalized Care with Acquisition of Mindstrong Technology
Provider of high-quality mental health care adds capabilities to deliver more perso…
ChatGPT: what are the ethical challenges for medical publishing?
Generative artificial intelligence (AI) is becoming increasingly prevalent in vario…
Pear Therapeutics Announces Process Exploring Strategic Alternatives
BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), th…